TY - JOUR
T1 - A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
AU - Koedijk, Joost B
AU - van der Werf, Inge
AU - Penter, Livius
AU - Vermeulen, Marijn A
AU - Barneh, Farnaz
AU - Perzolli, Alicia
AU - Meesters-Ensing, Joyce I
AU - Metselaar, Dennis S
AU - Margaritis, Thanasis
AU - Fiocco, Marta
AU - de Groot-Kruseman, Hester A
AU - Moeniralam, Rubina
AU - Bang Christensen, Kristina
AU - Porter, Billie
AU - Pfaff, Kathleen
AU - Garcia, Jacqueline S
AU - Rodig, Scott J
AU - Wu, Catherine J
AU - Hasle, Henrik
AU - Nierkens, Stefan
AU - Belderbos, Mirjam E
AU - Zwaan, C Michel
AU - Heidenreich, Olaf
AU - de Groot-Kruseman, Hester
N1 - © 2024. The Author(s).
PY - 2024/11
Y1 - 2024/11
N2 - Because of the low mutational burden and consequently, fewer potential neoantigens, children with acute myeloid leukemia (AML) are thought to have a T cell-depleted or 'cold' tumor microenvironment and may have a low likelihood of response to T cell-directed immunotherapies. Understanding the composition, phenotype, and spatial organization of T cells and other microenvironmental populations in the pediatric AML bone marrow (BM) is essential for informing future immunotherapeutic trials about targetable immune-evasion mechanisms specific to pediatric AML. Here, we conducted a multidimensional analysis of the tumor immune microenvironment in pediatric AML and non-leukemic controls. We demonstrated that nearly one-third of pediatric AML cases has an immune-infiltrated BM, which is characterized by a decreased ratio of M2- to M1-like macrophages. Furthermore, we detected the presence of large T cell networks, both with and without colocalizing B cells, in the BM and dissected the cellular composition of T- and B cell-rich aggregates using spatial transcriptomics. These analyses revealed that these aggregates are hotspots of CD8+ T cells, memory B cells, plasma cells and/or plasmablasts, and M1-like macrophages. Collectively, our study provides a multidimensional characterization of the BM immune microenvironment in pediatric AML and indicates starting points for further investigations into immunomodulatory mechanisms in this devastating disease.
AB - Because of the low mutational burden and consequently, fewer potential neoantigens, children with acute myeloid leukemia (AML) are thought to have a T cell-depleted or 'cold' tumor microenvironment and may have a low likelihood of response to T cell-directed immunotherapies. Understanding the composition, phenotype, and spatial organization of T cells and other microenvironmental populations in the pediatric AML bone marrow (BM) is essential for informing future immunotherapeutic trials about targetable immune-evasion mechanisms specific to pediatric AML. Here, we conducted a multidimensional analysis of the tumor immune microenvironment in pediatric AML and non-leukemic controls. We demonstrated that nearly one-third of pediatric AML cases has an immune-infiltrated BM, which is characterized by a decreased ratio of M2- to M1-like macrophages. Furthermore, we detected the presence of large T cell networks, both with and without colocalizing B cells, in the BM and dissected the cellular composition of T- and B cell-rich aggregates using spatial transcriptomics. These analyses revealed that these aggregates are hotspots of CD8+ T cells, memory B cells, plasma cells and/or plasmablasts, and M1-like macrophages. Collectively, our study provides a multidimensional characterization of the BM immune microenvironment in pediatric AML and indicates starting points for further investigations into immunomodulatory mechanisms in this devastating disease.
KW - Adolescent
KW - B-Lymphocytes/immunology
KW - Bone Marrow/pathology
KW - Case-Control Studies
KW - Child
KW - Child, Preschool
KW - Female
KW - Humans
KW - Infant
KW - Leukemia, Myeloid, Acute/immunology
KW - Macrophages/immunology
KW - Male
KW - Phenotype
KW - Tumor Microenvironment/immunology
UR - https://www.mendeley.com/catalogue/5e64486a-7346-38a4-b50e-22c33e287dd5/
U2 - 10.1038/s41375-024-02381-w
DO - 10.1038/s41375-024-02381-w
M3 - Article
C2 - 39187578
SN - 0887-6924
VL - 38
SP - 2332
EP - 2343
JO - Leukemia
JF - Leukemia
IS - 11
ER -